Japan T-Reg Venture RegCell Raises New Funds, Relocates To US

Lead Therapy Into Clinic This Year

RegCell HQ
A Japanese cell therapy venture RegCell relocated its HQ from Japan to US with $48.5m financing. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Japan

More from Business